The largest database of trusted experimental protocols

15 protocols using cd49f

1

Isolation of Mammary Stem and Cancer Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For isolation of MaSC and BCSCs, we used CD24lo and CD49fhi as markers for normal MaSC and CD44/CD24 double-positive for human BCSCs and CD49f/CD24 double-positive for mouse BCSCs as described in our previous manuscripts (15 (link), 21 (link)) and studies from other laboratories (22 (link), 23 (link)). We used the following antibodies for this study: CD49f and CD24 (STEMCELL Technology and eBioscience), CD45, CD31, CD49f, CD44 (BD bioscience), and Ter119 and CD61 (eBioscience). Blocking was done for 10 min with rat serum. Cells were stained for 30 min on ice and washed with staining media. Finally, cells were resuspended in staining media containing 7-aminoactinomycin D (1 μg/ml) or 4’−6-diamidino-2-phenylindole (DAPI, 1 μg/ml) to stain dead cells. Cells were sorted through Mo flow cell sorter and flow cytometry data was analyzed using LSR II and Flow-jo as described before in our manuscripts (15 (link), 21 (link)).
+ Open protocol
+ Expand
2

Phenotypic Characterization of Murine and Human Hematopoietic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
This was done using an LSRII cytometer or FACS Caliber (Becton Dickenson, San Diego, CA) and chromophore-conjugated antibodies used for mouse BM cell phenotyping (Mantel et al., 2010 (link); 2012 (link)). See also Figure S1C. Antibodies used for human phenotyping (Notta et al., 2011 (link)) were anti-lineage cocktail, CD34, CD38, CD45RA, CD90, and CD49f (BD Biosciences). For mitochondrial mass, membrane potential, and ROS analysis (Mantel et al., 2010 (link); 2012 (link)), we used Mitotracker Green FM, JC-1, and Mitotracker Orange CMTMRos respectively (Molecular Probes, Life Technologies; Grand Island, NY). CXCR4 antibodies were purchased from BD Biosciences. Phenotyping for mouse transplant chimerism/engraftment analysis was as noted (Mantel et al., 2012 (link); Broxmeyer et al., 2012 ). Flow cytometric analysis of apoptosis was assessed by activated caspase-3 (Mantel, et al., 2007 (link)).
+ Open protocol
+ Expand
3

Immunophenotypic Characterization of MISB10 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
MISB10 cells cultured in T75 flasks were treated with Accutase (BD Biosciences) and washed twice with PBS with 1% BSA. Suspensions were counted and measured for cell viability using the Vi-Cell XR cell counting and viability analyzer (Beckman Coulter). Cells were diluted in PBS to 1 × 106 cells/ml and stained for 30 min at RT with membrane viability dye (LIVE/DEAD Fixable Near-IR, Invitrogen). Cells were washed and distributed to a 96-well plate containing staining antibodies and Hoechst 33342 (Invitrogen). For characterization panels, immunophenotyping antibodies to the following targets were used: HER-2/neu, CD24, CD29, CD44, CD45, CD49f, CD90, CD166, CD326 (BD Biosciences), and CD133 (Miltenyi Biotec, Auburn, CA). Cells were incubated for 30 min at RT in the dark and then rinsed twice in PBS before acquisition with a BD LSRII flow cytometer. Analysis of results was performed using FACSDiva v6.1.3 and FlowJo analysis software (FlowJo).
+ Open protocol
+ Expand
4

Hematopoietic Stem Cell Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
For model development, surface marker staining was performed with conjugated human antibodies: CD34, CD38, CD45RA, CD90, CD49f, CD10, CD135, CD7, CD3, CD19, CD41, CD235a, CD11b, CD16, CD33, CD14 (BD Biosciences). Surface marker staining for validation experiments was performed with conjugated human antibodies: CD34, CD45RA, CD90 (BD Biosciences). All samples were analyzed on a FACSCanto or FACS LSRFortessa flow cytometer (BD Biosciences).
+ Open protocol
+ Expand
5

Characterization of Breast Cancer Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
BrCSCs were exposed to primary antibodies CD44 (BU75, Ancell), CD24 (ML5, R&D System), CD10 (FR4D11, Santa Cruz Biotechnology), CD49f (GoH3 Miltenyi Biotec), EpCAM (AF960, R&D System) or corresponding isotype controls, rinsed and labeled with secondary antibodies. BrCSCs were stained with CD49f and CD24 and successively sorted via flow cytometry using an FACSAria cell sorter (BD Biosciences). The analysis of ALDH1 activity was performed using the ALDEFLUOR kit (StemCell Technologies). For cell cycle analysis, BrCSCs were fixed in 70% ethanol and incubated with 50 μg/mL propidium iodide (Sigma-Aldrich), 3.8 mmol/L sodium citrate (Sigma) and 10 μg/mL RNase (Sigma). Samples were analyzed by FACSCalibur and CellQuest Software (BD Biosciences).
+ Open protocol
+ Expand
6

Characterizing Stem Cell Populations

Check if the same lab product or an alternative is used in the 5 most similar protocols
Before flow cytometry analysis or sorting, cells were dissociated as described above or washed and dissociated using TrypLE (Gibco, Carlsbad, CA, USA). Cells were resuspended in a 100μL staining volume of fluorescence activated cell sorting (FACS) buffer (Hanks' balanced salt solution + 0.1% bovine serum albumin) and kept on ice. The following antibodies were used: CD133/1, and CD133/2 biotin (Miltenyi Biotech, San Diego, CA, USA), CD90 (Biolegend, San Diego, CA, USA), CD15 (BD Bioscience, San Jose, CA, USA), CD49f (BD Bioscience, San Jose, CA, USA), AB25 (Miltenyi Biotech, San Diego, CA, USA) and PE-CY7 strep (BD Biosciences, San Jose, CA, USA). All analyses were conducted using a LSR II FACS machine (BD Biosciences, San Jose, CA, USA) or sorted on an ARIA-II (BD Biosciences, San Jose, CA, USA) at the Stanford University FACS facility. Appropriate isotype controls were used to control for nonspecific isotype background.
+ Open protocol
+ Expand
7

Isolation and Characterization of Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow aspiration was approved by the Inha University Hospital Institutional Review Board (IRB) and written informed consent was obtained from a healthy donor (IRB number #10-51). Highly homogeneous clonal MSCs were isolated from BM as described previously (30 (link)). Markers of MSCs were determined by flow cytometry using a number of specific antibodies, including CD14 (BD Biosciences, San Diego, CA, USA), CD29 (Serotech, Kidlington, UK), CD31 (Serotec), CD34 (BD Biosciences), CD44 (Serotec), CD45 (BD Biosciences), CD49f (BD Biosciences), CD73 (BD Biosciences), CD90 (BD Biosciences), CD105 (Serotec), CD106 (BD Biosciences), CD133 (BD Biosciences), CD166(Serotec), HLA-DR (BD Biosciences), HLA-Class I (BD Biosciences), CXCR4 (BD Biosciences), and Oct-4 (Cell Signaling Technology, Danvers, MA, USA). MSCs were positive for CD29, CD44, CD49f, CD73, CD90, CD105, CD166, HLA-Class I, and Oct-4 but were negative for C14, CD31, CD34, CD45, CD106, CD133, CXCR4, and HLA-DR (data not shown). For the assessment of differentiation potential, adipogenic, osteogenic, and chondrogenic differentiations were induced as described (6 (link)). MSCs isolated were successfully differentiated into these 3 mesenchymal cell types, indicating the multilineage differentiation potential (data not shown).
+ Open protocol
+ Expand
8

Multiparametric Immunofluorescence Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dorsal skin samples were embedded in OCT and sectioned at 8 µm thickness. Sections were fixed in formalin for 10 min, followed by two H2O washes (10 min each). Sections were blocked with blocking buffer (10% donkey serum in 1xPBST) for 1 h. Primary antibodies were diluted in blocking buffer and applied to the tissue and incubated overnight at 4 °C. Secondary antibodies were diluted in 1xPBST for 1 h at room temperature following three 1xPBST washes (5 min). Sections were washed in 1xPBST three times (5 min) and mounted with Fluoroshield with DAPI (Abcam, ab104139). Images were taken using the Leica DM7200 fluorescence imaging platform with LAS X version 3.7.5. Antibodies used: F4/80 1:600 (Biolegend, Cat#123101); Ly6G 1:600 (Biolegend, Cat#127601); CD3 1:800 (Biolegend, Cat#100201); Cox-2 1:600 (Cayman, Cat#160106); Ptges2 1:200 (Abclonal, Cat#A7137); Ptges3 1:200 (Abclonal, Cat#A5194); Ptger2 1:500 (Abcam, Cat#ab167171); Cd49f 1:100 (BD Biosciences, Cat#555734); Dct 1:600 (Abcam, Cat#ab221144), together with suitable Alex Fluor secondary antibodies (Abcam, Cat#ab150072, ab150149, ab150152, Fisher, Cat#A21207)
+ Open protocol
+ Expand
9

Immunohistochemical Analysis of Skin Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunochemistry and immunofluorescence were performed as described previously [44 (link)]. Skin samples were fixed in 4% PFA, paraffin-embedded 5-μm sections were stained with hematoxylin and eosin (H&E). For immunofluorescence staining, paraffin sections were microwave pretreated, and incubated with primary antibodies, then incubated with secondary antibodies (Invitrogen) and counterstained with DAPI in mounting media. The following antibodies and dilutions were used: K14 (rabbit, 1:1000, Covance), K14 (mouse, 1:500, Abcam),K5 (rabbit, 1:1000, Covance), Sox9 (rabbit, 1:100, Santa Cruz), AE13(mouse, 1:100, Abcam), AE15 (mouse, 1:100, Abcam), BrdU (rat, 1:200, Abcam), Cleaved Caspase-3 (rabbit, 1:100, Cell Signaling), Gata-3 (mouse, 1:100, Santa Cruz), K17 (rabbit, 1:100, Abcam), Foxn1 (mouse, 1:100, Santa Cruz), Dlx3 (rabbit, 1:100, Santa Cruz), Sostdc1 (rabbit, 1:100, Abcam), Hoxc13 (mouse, 1:100, Sigma), Lef1 (rabbit, 1:100, Cell Signaling), Ki67 (mouse, 1:100,Novacastra), Bmpr1a (rabbit, 1:100, Abcam), Msx2 (rabbit, 1:200, Santa Cruz), k15 (mouse, 1:150, Vector Labs), CD49f (rat,1:100,BD), p63 (mouse, 1:200, Santa Cruz), K10 (rabbit, 1:1000, Covance), Loricrin (rabbit, 1:500, Covance), K1 (rabbit, 1:500, Covance).
+ Open protocol
+ Expand
10

Characterizing Stem Cell Populations

Check if the same lab product or an alternative is used in the 5 most similar protocols
Before flow cytometry analysis or sorting, cells were dissociated as described above or washed and dissociated using TrypLE (Gibco, Carlsbad, CA, USA). Cells were resuspended in a 100μL staining volume of fluorescence activated cell sorting (FACS) buffer (Hanks' balanced salt solution + 0.1% bovine serum albumin) and kept on ice. The following antibodies were used: CD133/1, and CD133/2 biotin (Miltenyi Biotech, San Diego, CA, USA), CD90 (Biolegend, San Diego, CA, USA), CD15 (BD Bioscience, San Jose, CA, USA), CD49f (BD Bioscience, San Jose, CA, USA), AB25 (Miltenyi Biotech, San Diego, CA, USA) and PE-CY7 strep (BD Biosciences, San Jose, CA, USA). All analyses were conducted using a LSR II FACS machine (BD Biosciences, San Jose, CA, USA) or sorted on an ARIA-II (BD Biosciences, San Jose, CA, USA) at the Stanford University FACS facility. Appropriate isotype controls were used to control for nonspecific isotype background.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!